S100 Utility of endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in patients with nsclc
Sign Up to like & getrecommendations! Published in 2017 at "Thorax"
DOI: 10.1136/thoraxjnl-2017-210983.106
Abstract: Rationale Recent data have demonstrated the superiority of Pembroluzimab over chemotherapy for patients with advanced NSCLC and high (≥50% expression) of PD-L1.1 This has resulted in NICE approving Pembroluzimab as a first line treatment option for… read more here.
Keywords: testing patients; s100 utility; patients nsclc; high expression ... See more keywords